Péter Szelényi

Péter Szelényi

Auto-generated profile, based on publicly available information

Péter Szelényi

Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
MCMiklós Csala
Miklós Csala
TKTamás Kardon
Tamás Kardon
BLBalazs Legeza
Balazs Legeza
BLBeáta Lizák
Beáta Lizák
JMJózsef Mandl
József Mandl
GBGábor Bánhegyi
Gábor Bánhegyi

1 January 2013 in World Journal of Hepatology
Verified
Journal Article
Open access
VZVeronika Zámbó
Veronika Zámbó
LSLaura Simon-Szabó
Laura Simon-Szabó
PSPéter Szelényi
Péter Szelényi
ÉKÉva Kereszturi
Éva Kereszturi
GBGábor Bánhegyi
Gábor Bánhegyi
MCMiklós Csala
Miklós Csala
Obesity due to excessive food intake and the lack of physical activity is becoming one of the most serious public health problems of the 21(st) century. With the increasing prevalence of obesity, non-alcoholic fatty liver disease is also emerging as a pandemic. While previously this pathophysiological condition was mainly attributed to triglyceride accumulation in hepatocytes, recent data show that the development of oxidative stress, lipid peroxidation, cell death, inflammation and fibrosis are mostly due to accumulation of fatty acids, and the altered composition of membrane phospholipids. In fact, triglyceride accumulation might play a protective role, and the higher toxicity of saturated or trans fatty acids seems to be the consequence of a blockade in triglyceride synthesis. Increased membrane saturation can profoundly disturb cellular homeostasis by impairing the function of membrane receptors, channels and transporters. However, it also induces endoplasmic reticulum stress via novel sensing mechanisms of the organelle's stress receptors. The triggered signaling pathways in turn largely contribute to the development of insulin resistance and apoptosis. These findings have substantiated the lipotoxic liver injury hypothesis for the pathomechanism of hepatosteatosis. This minireview focuses on the metabolic and redox aspects of lipotoxicity and lipoapoptosis, with special regards on the involvement of endoplasmic reticulum stress responses.

8 September 2010 in Endocrinology
Verified
Journal Article
Closed access
SSSilvia Senesi
Silvia Senesi
BLBalazs Legeza
Balazs Legeza
ZBZoltán Balázs
Zoltán Balázs
MCMiklós Csala
Miklós Csala
PMPaola Marcolongo
Paola Marcolongo
ABAngelo Benedetti
Angelo Benedetti
Both fructose consumption and increased intracellular glucocorticoid activation have been implicated in the pathogenesis of the metabolic syndrome. Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) depends on hexose-6-phosphate dehydrogenase (H6PD), which physically interacts with 11β-HSD1 at the luminal surface of the endoplasmic reticulum (ER) membrane and generates reduced nicotinamide adenine dinucleotide phosphate for the reduction of glucocorticoids. The reducing equivalents for the reaction are provided by glucose-6-phosphate (G6P) that is transported by G6P translocase into the ER. Here, we show that fructose-6-phosphate (F6P) can substitute for G6P and is sufficient to maintain reductase activity of 11β-HSD1 in isolated microsomes. Our findings indicate that the mechanisms of F6P and G6P transport across the ER membrane are distinct and provide evidence that F6P is converted to G6P in the ER lumen, thus yielding substrate for H6PD-dependent reduced nicotinamide adenine dinucleotide phosphate generation. Using the purified enzyme, we show that F6P cannot be directly dehydrogenated by H6PD, and we also excluded H6PD as a phosphohexose isomerase. Therefore, we postulate the existence of an ER luminal hexose-phosphate isomerase different from the cytosolic enzyme. The results suggest that cytosolic F6P promotes prereceptor glucocorticoid activation in white adipose tissue, which might have a role in the pathophysiology of the metabolic syndrome.

Verified
Journal Article
Open access
PDF file
KTKinga Tibori
Kinga Tibori
GOGabriella Orosz
Gabriella Orosz
VZVeronika Zámbó
Veronika Zámbó
PSPéter Szelényi
Péter Szelényi
FSFarkas Sarnyai
Farkas Sarnyai
Kereszturi ÉvaKereszturi Éva
Kereszturi Éva
Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat storage and contributing to cellular defense against saturated fatty acid toxicity. Recent studies show that increased activity or over-expression of SCD1 is one of the contributing factors for type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of the common missense rs2234970 (M224L) polymorphism on SCD1 function in transfected cells. We found a higher expression of the minor Leu224 variant, which can be attributed to a combination of mRNA and protein stabilization. The latter was further enhanced by various fatty acids. The increased level of Leu224 variant resulted in an elevated unsaturated: saturated fatty acid ratio, due to higher oleate and palmitoleate contents. Accumulation of Leu224 variant was found in a T2DM patient group, however, the difference was statistically not significant. In conclusion, the minor variant of rs2234970 polymorphism might contribute to the development of obesity-related metabolic disorders, including T2DM, through an increased intracellular level of SCD1.

Verified
Journal Article
Open access
PDF file
FSFarkas Sarnyai
Farkas Sarnyai
ASAnna Somogyi
Anna Somogyi
ZGZsófia Gór-Nagy
Zsófia Gór-Nagy
VZVeronika Zámbó
Veronika Zámbó
PSPéter Szelényi
Péter Szelényi
MCMiklós Csala
Miklós Csala
Dietary trans fatty acids (TFAs) have been implicated in serious health risks, yet little is known about their cellular effects and metabolism. We aim to undertake an in vitro comparison of two representative TFAs (elaidate and vaccenate) to the best-characterized endogenous cis-unsaturated FA (oleate). The present study addresses the possible protective action of TFAs on palmitate-treated RINm5F insulinoma cells with special regards to apoptosis, endoplasmic reticulum stress and the underlying ceramide and diglyceride (DG) accumulation. Both TFAs significantly improved cell viability and reduced apoptosis in palmitate-treated cells. They mildly attenuated palmitate-induced XBP-1 mRNA cleavage and phosphorylation of eukaryotic initiation factor 2α (eIF2α) and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK), but they were markedly less potent than oleate. Accordingly, all the three unsaturated FAs markedly reduced cellular palmitate incorporation and prevented harmful ceramide and DG accumulation. However, more elaidate or vaccenate than oleate was inserted into ceramides and DGs. Our results revealed a protective effect of TFAs in short-term palmitate toxicity, yet they also provide important in vitro evidence and even a potential mechanism for unfavorable long-term health effects of TFAs compared to oleate.

29 November 2018 in BioFactors
Verified
Journal Article
Closed access
PDF file
PSPéter Szelényi
Péter Szelényi
ASAnna Somogyi
Anna Somogyi
FSFarkas Sarnyai
Farkas Sarnyai
VZVeronika Zámbó
Veronika Zámbó
LSLaura Simon‐Szabó
Laura Simon‐Szabó
MCMiklós Csala
Miklós Csala